Endomyocardial biopsy is utilized in the diagnostic workup of peripartum cardiomyopathy to immediately identify or exclude myocarditis due to important therapeutic implications.
PRIMARY myocardial disease that develops during the course of pregnancy is a rare but exacting diagnostic problem. The variation in the time of onset of this disease from the second trimester of pregnancy until well into the puerperium has led to debate regarding terminology.1 , 2 We refer to peripartum cardiomyopathy as the new presentation of primary myocardial disease during pregnancy or in the first five months after pregnancy.In the evaluation of patients with peripartum cardiomyopathy it is necessary to exclude or identify myocarditis immediately because of the important therapeutic implications. We have included endomyocardial biopsy in the diagnostic workup of . . .
Melvin et al. (Thu,) conducted a other in Peripartum cardiomyopathy. Endomyocardial biopsy was evaluated. Endomyocardial biopsy is utilized in the diagnostic workup of peripartum cardiomyopathy to immediately identify or exclude myocarditis due to important therapeutic implications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: